PAVmed Reflects on 2025 Achievements and Advances in Medical Technology PAVmed Inc. shares significant developments from the past year, enhancing its medical technology portfolio, strategic partnerships, and financial standing. Details on future plans and achievements are discussed.

PAVmed Reflects on 2025 Achievements and Advances in Medical Technology #USA #New_York #Lucid_Diagnostics #PAVmed #Veris_Health

PAVmed Strengthens Financial Position by Closing Preferred Stock and Note Financings Successfully PAVmed Inc. announces the successful closure of preferred stock and senior secured note financings, effectively eliminating previous convertible securities and strengthening its balance sheet remarkably.

PAVmed Strengthens Financial Position by Closing Preferred Stock and Note Financings Successfully #USA #New_York #EsoGuard #PAVmed #Veris_Health

PAVmed's Business Update for Q3 2025 Highlights Strategic Developments PAVmed Inc. shares business updates for Q3 2025, confirming strong financial results and innovative technological advancements in medical technology.

PAVmed's Business Update for Q3 2025 Highlights Strategic Developments #USA #New_York #Lucid_Diagnostics #PAVmed #Veris_Health

PAVmed and Ohio State University's Strategic Partnership Enhances Cancer Care PAVmed Inc.'s partnership with Ohio State University enhances personalized cancer care with the Veris Cancer Care Platform, empowering patients and providers alike.

PAVmed and Ohio State University's Strategic Partnership Enhances Cancer Care #USA #Columbus #PAVmed #Veris_Health #OSUCCC

PAVmed Updates Investors with Q2 2025 Financial Results and Business Developments PAVmed, a medical technology company, presents its second quarter 2025 financial results and essential business updates, showcasing growth and future strategies.

PAVmed Updates Investors with Q2 2025 Financial Results and Business Developments #United_States #New_York #Lucid_Diagnostics #PAVmed #Veris_Health

PAVmed's Subsidiary Veris Health Raises $2.5 Million in Equity Financing for Innovations PAVmed's subsidiary, Veris Health, successfully completed a $2.5 million equity financing to advance its innovative cancer care solutions, showcasing investor confidence.

PAVmed's Subsidiary Veris Health Raises $2.5 Million in Equity Financing for Innovations #USA #New_York #Cancer_Care #PAVmed #Veris_Health

PAVmed's Veris Health Partners with Ohio State University for Cancer Care Advancement PAVmed Inc.'s subsidiary Veris Health has entered a strategic partnership with The Ohio State University Comprehensive Cancer Center to enhance cancer patient care through innovative technology.

PAVmed's Veris Health Partners with Ohio State University for Cancer Care Advancement #United_States #Columbus #Cancer_Care #PAVmed #Veris_Health

PAVmed Reports First Quarter 2025 Financials and Business Progress PAVmed has provided its business update and financial results for Q1 2025, showcasing progress in diagnostics and plans for biopharma expansion.

PAVmed Reports First Quarter 2025 Financials and Business Progress #USA #New_York #Lucid_Diagnostics #PAVmed #Veris_Health

PAVmed Inc. Successfully Completes $2.37 Million Private Placement Financing for Cancer Care Innovations PAVmed Inc. announces successful completion of $2.37 million private placement financing to advance its Veris Health subsidiary for improved cancer patient care.

PAVmed Inc. Successfully Completes $2.37 Million Private Placement Financing for Cancer Care Innovations #United_States #New_York #Private_Placement #PAVmed #Veris_Health